NorgesInvestor
1
27M
1
0.04
1
- Stages of investment
- Areas of investment
Summary
The venture was found in Europe in Norway. The main office of represented VC is situated in the Oslo.
For fund there is a match between the location of its establishment and the land of its numerous investments - Norway. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Algeta. We can highlight the next thriving fund investment areas, such as Chemical, Biotechnology.
The important activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2007. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are SR One, HealthCap, Advent Venture Partners. In the next rounds fund is usually obtained by Abingworth.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.04
- Investments by industry
- Medical (1)
- Biotechnology (1)
- Chemical (1)
- Investments by region
-
- Norway (1)
- Peak activity year
- 2005
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Avg. valuation at time of investment
- 2B
- Group Appearance index
- 1.00
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Algeta | 02 Sep 2005 | Biotechnology, Medical, Chemical | Early Stage Venture | 27M | Oslo, Norway |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.